RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
Current treatment patterns and survival in relapsed or refractory multiple myeloma
Findings from a brief survey of European physicians
Davis, K., Lin, HM., Zhang, S., & Kaye, J. (2015). Current treatment patterns and survival in relapsed or refractory multiple myeloma: Findings from a brief survey of European physicians. Value in Health, 18(3), A1221-A1221. https://doi.org/10.1016/j.jval.2015.03.1284
Little data from real-world clinical settings in Europe are available describing treatment patterns and survival of relapsed/refractory multiple myeloma (RRMM) patients. This study begins to address this knowledge gap using data from a brief physician survey.